**Core Concept**
In a high-risk patient with hypertension, diabetes, obesity, and chronic aortoiliac obstruction, the goal of anesthesia management is to prevent thromboembolic events while maintaining cardiovascular stability. This requires careful consideration of anticoagulation and vasodilation strategies.

**Why the Correct Answer is Right**
Heparin is the correct answer because it is an anticoagulant that prevents thrombus formation, which is crucial in a patient with chronic aortoiliac obstruction. In a patient with a history of aortoiliac obstruction, the risk of thromboembolic events is increased, and heparin helps mitigate this risk. Additionally, heparin does not cross the placenta, making it a safe choice for anticoagulation in pregnancy.

**Why Each Wrong Option is Incorrect**
**Option A:** Labetalol is a vasodilator and antihypertensive agent, but it does not address the risk of thromboembolic events in a patient with chronic aortoiliac obstruction.

**Option B:** Statins are lipid-lowering agents that are not typically continued during pregnancy due to the risk of fetal abnormalities. They also do not have a direct effect on thromboembolic risk.

**Option C:** Magnesium sulphate is a calcium channel blocker and antihypertensive agent, but it does not provide anticoagulation and is not the primary choice for patients with chronic aortoiliac obstruction.

**Clinical Pearl / High-Yield Fact**
In high-risk patients undergoing elective cesarean section, a careful review of medications is essential to avoid unnecessary risks. This includes discontinuing medications that are not necessary or that pose a risk to the fetus, such as statins.

**✓ Correct Answer: D. Heparin**